Clinical Trial Update: The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to characterize the pharmacokinetics of a single-dose oral tetrahydrocannabinol and cannabidiol. It is sponsored by McMaster University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Cannabidiol (cannabidiol)
• Tetrahydrocannabinol (delta-9-tetrahydrocannabinol)

Snippet

Sponsor: McMaster University | Conditions: Cannabis, Chronic Kidney Diseases | Phase 1 | Status: ACTIVE_NOT_RECRUITING